Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
NEW YORK, March 26, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP has filed a class action lawsuit, Dishion v. Power Solutions International Inc. et al., No. 26 Civ. 3149, in the United States...
-
NEW YORK, March 26, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased Grocery Outlet Holdings Corp. (“Grocery Outlet” or the “Company”) (NASDAQ: GO) securities to...
-
NEW YORK, March 25, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds Franklin BSP Realty Trust (“Franklin” or the “Company”) (NYSE:FBRT) investors of the April 27, 2026 lead...
-
NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP continues its investigation on behalf of Weis Markets, Inc. (“Weis Markets” or the “Company”) (NYSE:WMK) investors...
-
NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- If you suffered a loss on your investment in Corcept Therapeutics Incorporated (“Corcept” or the “Company”) (NASDAQ:CORT), contact Lauren Molinaro by...
-
NEW YORK, March 23, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of Arq, Inc. (“Arq” or the “Company”) (NASDAQ:ARQ) investors concerning...
-
NEW YORK, March 23, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP continues its investigation on behalf of Stellantis N.V. (“Stellantis” or the “Company”) (NYSE: STLA) investors...
-
NEW YORK, March 23, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP continues its investigation on behalf of Fulgent Genetics Inc. (“Fulgent” or the “Company”) (NASDAQ:FLGT) investors...
-
NEW YORK, March 20, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of Arq, Inc. (“Arq” or the “Company”) (NASDAQ:ARQ) investors concerning...
-
NEW YORK, March 20, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NASDAQ:SLNO) securities to contact Lauren...